pembrolizumab
merck
['vance', 'sclc', 'pembro', 'nsclc']
new poster! i will be attending #esmo22 congress (paris, france) this weekend. predictive factors of efficacy to pembrolizumab in advanced nsclc patients with high pd-l1 expression . check my poster on monday 12th september 2022!
Medical Oncology Resident at Hospital de la Santa Creu i Sant Pau, Barcelona, Spain